"Congressional Committee Urges FDA Action on CBD Regulations"

A congressional committee held a hearing to address the Food and Drug Administration's (FDA) inaction on developing regulations for hemp-derived CBD as food items or dietary supplements. Lawmakers criticized the FDA for not using its existing authority to regulate CBD products and called for clear guidance and certainty in the market. The hemp industry has been struggling due to the lack of regulations, which has allowed potentially unsafe products to flood the market. Witnesses at the hearing emphasized the need for federal regulation to ensure safety standards and protect consumers. Bipartisan lawmakers have introduced bills to provide a pathway for the regulation of hemp derivatives like CBD.